Evidence mapPaperPMID 41584270Full record

ReviewKidney international reports2026

Improving Lifelong Comprehensive Care Coordination in Nephropathic Cystinosis: Multidisciplinary Perspectives.

Ladan Golestaneh, Elizabeth G Ames, Maya H Doyle, Cybele Ghossein, Paul C Grimm, Jennifer L Hewlett, Alaena Lim, Lauren S Marzinelli, Kimberly J Schmidt, Bonnie Smeryage and 2 more

Abstract readReview
In one paragraph

Review in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ladan GolestanehDepartment of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, Connecticut, USA.
Elizabeth G AmesDepartment of Pediatrics, Division of Pediatric Genetics, Metabolism & Genomic Medicine, and Department of Internal Medicine, Division of Genetic Medicine, Michigan Medicine, Ann Arbor, Michigan, USA.
Maya H DoyleDepartment of Social Work, School of Health Sciences, Quinnipiac University, Hamden, Connecticut, USA.
Cybele GhosseinDepartment of Medicine, Division of Nephrology & Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Paul C GrimmDepartment of Pediatrics, Division of Nephrology, Stanford Medicine, Palo Alto, California, USA.
Jennifer L HewlettDepartment of Pharmacy, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Alaena LimDepartment of Human Genetics, Emory School of Medicine, Atlanta, Georgia, USA.
Lauren S MarzinelliDivision of Nephrology & Hypertension, Northwestern Medicine, Chicago, Illinois, USA.
Kimberly J SchmidtGenetics and Metabolic Clinic, St. Luke's Health System, Boise, Idaho, USA.
Bonnie SmeryageDivision of Pediatric Nephrology, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA.
Joshua J ZaritskyDivision of Nephrology, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Frederick J KaskelDivision of Pediatric Nephrology, Children's Hospital at Montefiore, Bronx, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephropathic cystinosis is a rare lysosomal storage disorder characterized by cellular cystine accumulation and progressive multiorgan damage. Before advances in diagnostics, transplantation, and disease-modifying therapy, cystinosis was considered a fatal pediatric disease, with most patients reaching kidney failure by approximately 10 years of age. Life expectancy has now expanded into the 50s and beyond, and the disease has been transformed into a chronic condition with a predominantly extrarenal phenotype in adulthood. Traditionally, nephrologists have played a central role as cystinosis "care quarterbacks" in pediatric settings, and patients often expect this to continue after transitioning to adult care. As such, nephrologists are increasingly tasked with monitoring for and addressing complications in organs other than the kidneys, in addition to coordinating referrals to clinicians within the nephrology clinic (e.g., nurses, advanced practice providers, pharmacists, dietitians, social workers, care coordinators, and transplant specialists) and across multiple specialties (e.g., neurologists, gastroenterologists, endocrinologists, ophthalmologists, and orthopedists). Although recently published expert guidance offers recommendations for the multidisciplinary management of cystinosis, gaps in the literature exist around strategies to reduce care fragmentation, overcome collaboration challenges, and enhance patient/family and clinician experiences. This review aimed to explore various approaches for care delivery optimization across the lifespan of patients with cystinosis as well as improve the current understanding of disease-, patient-, provider-, and system-related factors that influence treatment adherence, engagement, and long-term outcomes.

Indexed as

care coordinationcystinosisintegrated carelysosomal storage disordermultidisciplinary carerare disease

Identifiers

PMID41584270
PMCPMC12828517

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.